These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12436594)

  • 1. [Glucose metabolism in myocardium and an assessment of myocardial viability by 18FDG-PET].
    Ogiu N; Nakai K; Hiramori K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):636-40. PubMed ID: 12436594
    [No Abstract]   [Full Text] [Related]  

  • 2. Reverse flow-metabolism mismatch: what does it mean?
    Schwaiger M; Pirich C
    J Nucl Med; 1999 Sep; 40(9):1499-502. PubMed ID: 10492371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of myocardial viability in patients with old myocardial infarction using 18F-deoxyglucose and positron emission tomography].
    Yamamoto Y; Nonogi H
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):873-6. PubMed ID: 12440070
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical usefulness of positron emission tomography (PET) in the evaluation of myocardial viability].
    Coma-Canella I; García Velloso MJ
    Rev Esp Cardiol; 1997 Sep; 50(9):605-11. PubMed ID: 9380930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of myocardial vitality with FDG-PET: still research or ready for general practice?].
    Schröter G; Schwaiger M
    Herz; 1995 Oct; 20(5):350-3. PubMed ID: 7498882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of myocardial viability by FDG-PET].
    Momose M; Kondo C
    Rinsho Byori; 2007 Jul; 55(7):639-47. PubMed ID: 17718060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accumulation of fluorodeoxyglucose in ischemic myocardium--II. Comparison with myocardial perfusion and regional wall motion].
    Tamaki N; Yonekura Y; Senda M; Saji H; Yamamoto K; Nishizawa S; Shibata T; Fudo T; Hashimoto T; Kambara H
    Kaku Igaku; 1987 Oct; 24(10):1529-38. PubMed ID: 3502008
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of myocardial glucose metabolism in rats with PET using wavelet analysis techniques.
    Arhjoul L; Bentourkia M
    Comput Med Imaging Graph; 2005 Jul; 29(5):357-65. PubMed ID: 15893914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of myocardial viability: using coronary pressure and flow after acute myocardial infarction.
    Kern MJ
    Heart; 2003 Jan; 89(1):9-10. PubMed ID: 12482779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging modalities for detection of myocardial viability.
    Underwood R
    MAGMA; 1998 Sep; 6(2-3):137-9. PubMed ID: 9803388
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment).
    Kobylecka M; Mączewska J; Fronczewska-Wieniawska K; Mazurek T; Płazińska MT; Królicki L
    Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):52-60. PubMed ID: 23047574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial metabolism and perfusion assessed by positron emission tomography].
    Torizuka K; Tamaki N; Yonekura Y; Yamashita K; Ohtani H; Magada Y; Fujibayashi Y; Fujita T; Sasayama S; Konishi J
    Kokyu To Junkan; 1990 Apr; 38(4):309-20. PubMed ID: 2194256
    [No Abstract]   [Full Text] [Related]  

  • 17. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial viability with MR--the Cologne perspective.
    Baer FM; Theissen P; Crnac J; Schmidt M
    MAGMA; 1998 Sep; 6(2-3):140-2. PubMed ID: 9803389
    [No Abstract]   [Full Text] [Related]  

  • 19. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Schelbert HR
    J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.